SEE TAI SANDI (Chief Development Officer) sold 0.6% of their position (386.00 shares) of LEXEO THERAPEUTICS, INC. on the open market
Open‑market sale worth $3.6K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 11/20/2025ACC: 0002009350-25-000005
Officer· Chief Development Officer
Since Feb 2024
-386.00
Net shares
Net seller
$3.6K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
386.00 disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−386.00
Price / share
$9.27
Trade value
$3.58K
% of position
0.6%
11/18/2025
65.86K→65.48K
Total
Net shares
−386.00
Net value
-$3.58K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/18/2025 | S · Sale | −386.00 | $9.27 | $3.58K | 0.6% | 65.86K | 65.48K |
| Total | −386.00 | -$3.58K | ||||||
Derivative Transactions0
No derivative transactions reported